Healthcare Co.,Ltd. (SHA:603313)
8.20
-0.09 (-1.09%)
Jun 19, 2025, 2:45 PM CST
Healthcare Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -112.52 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 | Upgrade
|
Depreciation & Amortization | 542.03 | 542.03 | 505.67 | 444.06 | 360.07 | 132.97 | Upgrade
|
Other Amortization | 194.46 | 194.46 | 136.55 | 97.86 | 80.25 | 67.17 | Upgrade
|
Loss (Gain) From Sale of Assets | -14.96 | -14.96 | -0.87 | 0.4 | 0.5 | -1.27 | Upgrade
|
Asset Writedown & Restructuring Costs | 36.79 | 36.79 | 14.67 | 4.72 | 4.76 | 2.36 | Upgrade
|
Loss (Gain) From Sale of Investments | 14.85 | 14.85 | 5.5 | -25.92 | -22.09 | -33.12 | Upgrade
|
Provision & Write-off of Bad Debts | 374.45 | 374.45 | 81.73 | 39.55 | 80.96 | 34.74 | Upgrade
|
Other Operating Activities | 127.9 | 148.24 | 233.75 | 92.19 | 270.66 | 230.65 | Upgrade
|
Change in Accounts Receivable | -266.43 | -266.43 | -358.17 | -61.16 | -289.22 | -293.6 | Upgrade
|
Change in Inventory | 65.49 | 65.49 | -10.89 | 191.97 | -594.39 | -628.25 | Upgrade
|
Change in Accounts Payable | 101.81 | 101.81 | 256.95 | -231.99 | 529.57 | 738.84 | Upgrade
|
Change in Other Net Operating Assets | - | - | - | - | -6.36 | 0.53 | Upgrade
|
Operating Cash Flow | 982.46 | 963.9 | 916.62 | 565.39 | 67.92 | 582.53 | Upgrade
|
Operating Cash Flow Growth | 14.77% | 5.16% | 62.12% | 732.41% | -88.34% | 348.81% | Upgrade
|
Capital Expenditures | -387.74 | -379.33 | -414.53 | -631.07 | -539.44 | -915.43 | Upgrade
|
Sale of Property, Plant & Equipment | 71.3 | 71.93 | 3.98 | 15.74 | 9.81 | 28.93 | Upgrade
|
Cash Acquisitions | -6.75 | -4.03 | - | - | - | -356.29 | Upgrade
|
Divestitures | -1.4 | - | 52.4 | 37.83 | - | - | Upgrade
|
Investment in Securities | 8.75 | -70.25 | 2.25 | 18.03 | -16 | -85.78 | Upgrade
|
Other Investing Activities | -15.3 | -13.41 | -7 | 10.48 | 24.61 | -2.19 | Upgrade
|
Investing Cash Flow | -331.13 | -395.1 | -362.9 | -548.89 | -523.5 | -1,305 | Upgrade
|
Short-Term Debt Issued | - | 200.7 | 431.6 | 795.03 | 40 | - | Upgrade
|
Long-Term Debt Issued | - | 2,856 | 2,925 | 3,410 | 3,402 | 2,447 | Upgrade
|
Total Debt Issued | 3,053 | 3,056 | 3,356 | 4,205 | 3,442 | 2,447 | Upgrade
|
Long-Term Debt Repaid | - | -3,679 | -4,049 | -4,555 | -2,690 | -1,921 | Upgrade
|
Net Debt Issued (Repaid) | -564.13 | -622.92 | -692.11 | -350.12 | 751.47 | 526.12 | Upgrade
|
Issuance of Common Stock | - | - | 789.19 | - | - | 686.34 | Upgrade
|
Repurchase of Common Stock | - | - | - | -6.94 | -6.44 | -0.67 | Upgrade
|
Common Dividends Paid | -140.92 | -125.82 | -151.76 | -135.52 | -258.37 | -71.32 | Upgrade
|
Other Financing Activities | -22.31 | -29.6 | -53.57 | -18.44 | -123.09 | -0.93 | Upgrade
|
Financing Cash Flow | -727.36 | -778.35 | -108.25 | -511.02 | 363.57 | 1,140 | Upgrade
|
Foreign Exchange Rate Adjustments | 53.47 | 24.54 | 91.76 | 170.2 | -192.26 | -160.75 | Upgrade
|
Net Cash Flow | -22.57 | -185.01 | 537.23 | -324.32 | -284.27 | 256.15 | Upgrade
|
Free Cash Flow | 594.72 | 584.57 | 502.1 | -65.68 | -471.52 | -332.91 | Upgrade
|
Free Cash Flow Growth | 32.79% | 16.43% | - | - | - | - | Upgrade
|
Free Cash Flow Margin | 6.86% | 6.92% | 6.30% | -0.82% | -5.79% | -5.10% | Upgrade
|
Free Cash Flow Per Share | 1.10 | 1.04 | 1.04 | -0.14 | -0.97 | -0.74 | Upgrade
|
Cash Income Tax Paid | 57.41 | 71.38 | 14.31 | -22.13 | -317.37 | -106.31 | Upgrade
|
Levered Free Cash Flow | 720.52 | 741.35 | 424.38 | -355.18 | -414.99 | -395.15 | Upgrade
|
Unlevered Free Cash Flow | 827.01 | 855.09 | 558.15 | -241.24 | -327.17 | -344.99 | Upgrade
|
Change in Net Working Capital | -454.91 | -492.99 | -28.64 | 312.94 | 288.34 | 68.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.